Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Cancer

GRAIL Says Galleri Demand Is Rising as NHS Talks, FDA Review Move Ahead

GRAIL (NASDAQ:GRAL) said demand for its Galleri multi-cancer early detection test has continued to grow despite recent headlines related to its NHS study, according to comments made by Aaron, who identified himself during the discussion as the company’s CFO, at a Bank of America event. Aaron said t

MarketBeat

Friends who were diagnosed with cancer weeks apart launch charity run

Alison Garven and Kirsty Ogilvie sounded the starting horn at the Race for Life.

The Independent UK

UK healthcare expansion: Steve Jobs son Reed Jobs plans to invest in cancer startups

Reed Jobs, the son of late Apple co-founder Steve Jobs, is looking to expand investments in British healthcare startups through his oncology-focused venture firm as he pushes efforts to improve cancer treatment and early detection.

The Times of India

From analysis to the latest developments in health,
read the most diverse news in one place.

How Nike founder Phil Knight’s $2 billion gift is reshaping cancer care in America

Phil and Penny Knight's $2 billion donation to OHSU's Knight Cancer Institute exemplifies legacy-changing philanthropy, moving beyond spontaneous "lightning strikes." This significant gift, the largest to an American academic medical center, is the culmination of a decade-long strategic commitment, demonstrating how sustained dedication and proven organizational capability can revolutionize healthcare…

The Times of India

Cancer patients among dozens ‘harmed’ by delayed diagnosis and treatment at NHS trust

Exclusive: Audit of hundreds of women’s cases prompted by concerns that necessary follow-ups were not carried out

The Independent UK

Erasca Touts 'Eye-Popping' ERAS-0015 Lung Cancer Data, FDA Path at BofA Conference

Erasca (NASDAQ:ERAS) executives said the company sees multiple potential development paths for its RAS-targeting portfolio, highlighting early clinical activity for ERAS-0015 in lung, pancreatic and colorectal cancers during a Bank of America biotech conference session. Jonathan Lim, Erasca’s chair

MarketBeat

Woman sees red spot on tongue but specialists call it stress-caused lesion. 6 months later, 37% of her tongue had to be removed

"You're not a smoker, not a drinker, and not a man."

We Got This Covered

Read news from The Economist, FT, and more,
with one subscription

When should you get a mammogram? The latest information amid conflicting advice

Information around routine mammograms in the US is confusing. Here is what you need to know

The Independent UK

‘Research here is world class’: son of Steve Jobs looks to invest in UK cancer care

After death of his father, Reed Jobs is keen for his $1bn venture capital fund Yosemite to make a difference

The Guardian - UK

JFK’s grandson Jack Schlossberg opens up about sister Tatiana’s tragic death: ‘The world will never be the same for me’

The granddaughter of the late President John F. Kennedy and Jacqueline Kennedy Onassis was diagnosed with an aggressive form of blood cancer in 2024

The Independent UK

Longtime BBC panellist admits ‘I don’t know how long I’ve got to live’ in last appearance on gardening show

Matthew Biggs has been a regular on Gardeners’ Question Time since 1994

The Independent UK

6 Cutting-Edge Cancer Treatments Younger Patients Are Asking Their Oncologists About

Cancer care is changing fast, and younger patients are paying close attention to the newest options available. Many people in their 20s, 30s, and 40s are now researching advanced therapies before they even step into an oncology office. Instead of accepting traditional chemotherapy as the only path forward, they are…

Budget and the Bees

Matthew Glaetzer: ‘Knowing that I’m never alone was a big part of being able to get through cancer’

The champion cyclist on the love of his life, surviving thyroid cancer, and what it felt like to win an Olympic medal after coming fourth, again and again

The Guardian - AU

MiNK Therapeutics Q1 Earnings Call Highlights

MiNK Therapeutics (NASDAQ:INKT) said it is advancing its off-the-shelf invariant natural killer T cell therapy platform into a randomized clinical program for severe acute lung injury and acute respiratory distress syndrome, while also reporting first-quarter 2026 financial results that management s

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

Metal Hammer

"I'd never been that close to death before." Ex-Metallica bassist Jason Newsted opens up on recent cancer battle - and why he's determined to get back to touring as soon as possible

Jason Newsted recently got the all-clear from throat cancer

BANG Premier

Drake reveals father's cancer battle in new song

The 39-year-old rapper dropped tune Make Them Cry, from his new Iceman album, on Thursday - as well as two other records titled Maid of Honour and Habibti.

The Independent UK

New blood test could show if prostate cancer treatment is failing

The discovery could lead to personalised treatments for the disease

MarketBeat

CG Oncology BLA Filing on Track as Key Bladder Cancer Data Nears

CG Oncology (NASDAQ:CGON) executives said the company remains on track to complete a rolling biologics license application for cretostimogene in BCG-unresponsive high-risk non-muscle invasive bladder cancer by the fourth quarter, while reiterating expectations for top-line data from a separate Phase

Get all your
news in one place.

100's of premium titles.
One news app.

International Business Times UK

Kate Middleton Hits Back: Prince William's Wife Defies 'Sick Backlash' on First Overseas Trip Since Cancer

Kate Middleton's first overseas engagement since cancer remission took her to Italy to promote her early years campaign, as she pressed on despite public backlash and reported private concerns from Prince William.

The Guardian - UK

Prostate cancer screening can save lives but ‘absolute benefit is small’, study says

Although blood test reduces deaths by two for every 1,000 men screened, many could face unnecessary treatment

MarketBeat

Celcuity Q1 Earnings Call Highlights

Celcuity (NASDAQ:CELC) reported a wider first-quarter loss as the biotechnology company increased spending tied to commercial launch preparations and continued development of gedatolisib, its investigational therapy for hormone receptor-positive, HER2-negative advanced breast cancer. On the company

International Business Times UK

Is King Charles Cancer-Free? Monarch Reportedly Undergoing 'Very Expensive' Experimental RNA Treatment

Royal editor Tom Sykes claims King Charles has been treated with an 'incredibly novel' and costly combination of immunotherapy and RNA drugs, raising hopes over the monarch's long‑term prognosis.

MarketBeat

Bicara Therapeutics Touts Cancer Drug Progress Ahead of 2026 Pivotal Data

Bicara Therapeutics (NASDAQ:BCAX) said its lead cancer drug candidate, ficerafusp alfa, remains on track for pivotal data in head and neck cancer in mid-2026, as the company outlined its development strategy and competitive positioning at the Bank of America Healthcare Conference. Ryan Kohlhepp of

The Independent UK

Unproven cancer drug prescriptions more than doubled after Joe Rogan podcast

IN FULL

The Independent UK

More cancer patients are using the alternative treatment ivermectin and Joe Rogan’s podcast may be the reason why

Researchers said the spike in prescriptions was a sign that Americans are turning towards unofficial sources for medical information in times of crisis

1 … 30 31 32 33

People

Jacqueline Kennedy Onassis

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

University College London

191 stories

BBC Radio 4

178 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.